Search Results
Aug 31, 2026, 16:30 ET Cisco to Participate in September Events with the Financial Community
SAN JOSE, Calif., Aug. 31, 2026 /PRNewswire/ -- Cisco (NASDAQ: CSCO) will participate in the following events with the financial community in September:
More news about: Cisco Systems, Inc.
Aug 25, 2026, 08:00 ET Cisco Expands Secure AI Factory with NVIDIA for the Rack-Scale Era
compute through validated, full-stack architectures customers can deploy quickly, run efficiently, and secure with confidence. Today, Cisco (Nasdaq: CSCO) is expanding the
More news about: Cisco Systems, Inc.
Aug 18, 2026, 20:15 ET CARsgen Therapeutics Announces 2026 Interim Results
market recognition.Satri-cel has been included in 2026 China Society of Clinical Oncology (CSCO) Guidelines for Diagnosis and Treatment of Gastric Cancer issued by CSCO, and China Anti-Cancer Association (CACA) Guidelines for Commercial Insurance Application of Innovative Oncology
More news about: CARsgen Therapeutics
Aug 17, 2026, 07:18 ET Kelun-Biotech Announces 2026 Interim Results
foundation of our products.Recognized through authoritative endorsement from clinical guideline experts, as reflected in guidelines (CSCO, etc.) and clinical expert consensus.佳泰莱® is recognized as the "standard of care in 2L and the preferred regimen in 3L" in the LC,
More news about: Kelun-biotech
Aug 12, 2026, 16:05 ET CISCO REPORTS FOURTH QUARTER AND FISCAL YEAR 2026 EARNINGS
$72.2 billion to $73.4 billionEarnings per Share: GAAP: $4.00 to $4.06; Non-GAAP: $5.05 to $5.11Cisco (NASDAQ: CSCO) today reported fourth quarter and fiscal year results for the period ended July 25, 2026. Cisco reported fourth quarter revenue of $17.3 billion, net
More news about: Cisco Systems, Inc.
Aug 05, 2026, 16:30 ET Cisco Schedules Conference Call for Q4 Fiscal Year 2026 Financial Results
SAN JOSE, Calif., Aug. 5, 2026 /PRNewswire/ -- Cisco (NASDAQ: CSCO) has scheduled a conference call for Wednesday, Aug 12, 2026, at 1:30 PM (PT); 4:30 PM (ET) to announce its fourth quarter fiscal year 2026 financial results
More news about: Cisco Systems, Inc.
Jun 04, 2026, 04:19 ET Lupeng Pharmaceutical's Fourth-Generation BTK Inhibitor Rocbrutinib Approved in China for Relapsed or Refractory Mantle Cell Lymphoma
inhibitor–associated toxicity was relatively low.In April 2026, rocbrutinib was included for the first time in the Chinese Society of Clinical Oncology (CSCO) Guidelines for the Diagnosis and Treatment of Lymphoma , where it was listed as a Category II recommendation for the treatment of R/R MCL. Its inclusion
More news about: Lupeng Pharmaceutical Ltd
Jun 02, 2026, 09:30 ET Early Data Show Highly Selective FGFR2 Inhibitor 3HP-2827 Active in Advanced CCA; Chinese Academy of Sciences' Zhou Jian Comments on Potential for Patients With FGFR2 Alterations
Association, Chairman of the Asia-Pacific Primary Liver Cancer Expert (APPLE) Association, and Chairman of the Chinese Society of Clinical Oncology (CSCO) Expert Committee on Hepatocellular Carcinoma. He also serves on the Executive Council of the Asian Pacific Association for the Study of the Liver (APASL)
More news about: 3H Pharmaceuticals
Jun 02, 2026, 09:00 ET Cisco Unveils Agentic Platform for Operating and Defending Critical IT Infrastructure
Cisco IQ: Intelligence that Elevates PartnersAbout CiscoCisco (NASDAQ: CSCO) is the worldwide technology leader that is revolutionizing the way organizations connect and protect in the AI era. For more than 40 years, Cisco has
More news about: Cisco Systems, Inc.
Jun 02, 2026, 09:00 ET Cisco Unveils Agentic Platform for Operating and Defending Critical IT Infrastructure
Cisco IQ: Intelligence that Elevates PartnersAbout CiscoCisco (NASDAQ: CSCO) is the worldwide technology leader that is revolutionizing the way organizations connect and protect in the AI era. For more than 40 years, Cisco has
More news about: Cisco Systems, Inc.
May 19, 2026, 10:45 ET Automation Anywhere Collaborates with Cisco, NVIDIA, Okta, and OpenAI, Launching EnterpriseClaw to Run Next-Generation AI Agents Inside Enterprise Systems
EnterpriseClaw. Developed in collaboration with Cisco (NASDAQ: CSCO), NVIDIA (NASDAQ: NVDA), Okta (NASDAQ: OKTA), and OpenAI, a new capability designed to make claw-style AI agents effective across enterprise operations.
More news about: Automation Anywhere
May 19, 2026, 08:00 ET The $600 Billion Wake-up Call: New Splunk Research Reveals Downtime is a Systemic Business Crisis
Officers), and marketing functions (including Chief Marketing Officers).About CiscoCisco (NASDAQ: CSCO) is the worldwide technology leader that is revolutionizing the way organizations connect and protect in the AI era. For more than 40 years, Cisco
More news about: Cisco Systems, Inc.
May 13, 2026, 16:05 ET CISCO REPORTS THIRD QUARTER EARNINGS
(1) EPS guidance includes the estimated impact of tariffs based on current trade policy.Cisco (NASDAQ: CSCO) today reported third quarter results for the period ended April 25, 2026. Cisco reported third quarter revenue of $15.8 billion, net income on a generally
More news about: Cisco Systems, Inc.
May 07, 2026, 09:00 ET Cisco to Participate in May & June Events with the Financial Community
SAN JOSE, Calif., May 7, 2026 /PRNewswire/ -- Cisco (NASDAQ: CSCO) will participate in the following events with the financial community in May & June:
More news about: Cisco
May 01, 2026, 16:30 ET Cisco Schedules Conference Call for Q3 Fiscal Year 2026 Financial Results
SAN JOSE, Calif., May 1, 2026 /PRNewswire/ -- Cisco (NASDAQ: CSCO) has scheduled a conference call for Wednesday, May 13, 2026, at 1:30 PM (PT); 4:30 PM (ET) to announce its third quarter fiscal year 2026 financial results
More news about: Cisco Systems, Inc.
Apr 28, 2026, 04:07 ET Ivonescimab Receives Major Recommendations Across Multiple Therapies in the 2026 CSCO NSCLC Guideline
multiple authoritative updates and upgrades across first-line and later-line settings in the officially updated 2026 Chinese Society of Clinical Oncology (CSCO) Guideline for the Diagnosis and Treatment of Non-Small Cell Lung Cancer (NSCLC). These strong recommendations further solidify ivonescimab's breakthrough
More news about: Akeso, Inc.
Apr 26, 2026, 21:50 ET 亞盛醫藥Bcl-2抑制劑利生妥®獲 2026 版 CSCO系列指南多項重磅推薦
致力於在腫瘤等領域開發創新藥物的領先的生物醫藥企業——亞盛醫藥（納斯達克代碼：AAPG；香港聯交所代碼：6855）今日宣佈，公司自主研發的1類新藥、中國首個上市的國產原創Bcl-2抑制劑利生妥®（利沙托克拉），獲納入最新發佈的2026年中國臨床腫瘤學會（CSCO）系列指南。在2026 版《CSCO 淋巴瘤診療指南》與《CSCO 惡性血液病診療指南》中，利沙托克拉憑借在多項臨床研究中的卓越表現，正式確立了在慢性淋巴細胞白血病/小淋巴細胞淋巴癌（CLL/SLL）、急性髓系白血病（AML）和骨髓增生異常綜合征（MDS）領域的權威推薦地位 。
More news about: 亞盛醫藥
Apr 23, 2026, 09:00 ET Cisco Introduces Universal Quantum Switch, Advancing the Path to a Quantum Network
on ArXiv.SAN JOSE, Calif., April 23, 2026 /PRNewswire/ -- Cisco (NASDAQ: CSCO) today announced the Cisco Universal Quantum Switch, a critical milestone in quantum networking that addresses one of the most fundamental barriers to
More news about: Cisco Systems, Inc.
Apr 23, 2026, 09:00 ET Cisco Introduces Universal Quantum Switch, Advancing the Path to a Quantum Network
on ArXiv.SAN JOSE, Calif., April 23, 2026 /PRNewswire/ -- Cisco (NASDAQ: CSCO) today announced the Cisco Universal Quantum Switch, a critical milestone in quantum networking that addresses one of the most fundamental barriers to
More news about: Cisco Systems, Inc.
Apr 07, 2026, 09:00 ET Cisco Research: Industrial AI Moves into Physical Operations, Readiness Gaps Determine Scale
cybersecurity.SAN JOSE, Calif., April 7, 2026 /PRNewswire/ -- Cisco (NASDAQ: CSCO) today announced the release of its latest annual industrial research report, the
More news about: Cisco Systems, Inc.
Apr 07, 2026, 09:00 ET Cisco Research: Industrial AI Moves into Physical Operations, Readiness Gaps Determine Scale
cybersecurity.SAN JOSE, Calif., April 7, 2026 /PRNewswire/ -- Cisco (NASDAQ: CSCO) today announced the release of its latest annual industrial research report, the
More news about: Cisco Systems, Inc.
Apr 06, 2026, 16:05 ET Cisco Appoints Pete Shimer to its Board of Directors
era.SAN JOSE, Calif., April 6, 2026 /PRNewswire/ -- Cisco (NASDAQ: CSCO) today announced the appointment of Pete Shimer to its board of directors, effective immediately.
More news about: Cisco Systems, Inc.
Apr 02, 2026, 11:00 ET Cisco Report: Strategic Wireless Investments are Driving Higher ROI for Enterprises in the AI Era
Breaking the wireless AI paradox: Turning challenges into competitive advantageAbout CiscoCisco (NASDAQ: CSCO) is the worldwide technology leader that is revolutionizing the way organizations connect and protect in the AI era. For more than 40 years, Cisco has
More news about: Cisco Systems, Inc.
Apr 02, 2026, 11:00 ET Cisco Report: Strategic Wireless Investments are Driving Higher ROI for Enterprises in the AI Era
Breaking the wireless AI paradox: Turning challenges into competitive advantageAbout CiscoCisco (NASDAQ: CSCO) is the worldwide technology leader that is revolutionizing the way organizations connect and protect in the AI era. For more than 40 years, Cisco has
More news about: Cisco Systems, Inc.
Mar 31, 2026, 08:13 ET 3SBio Announces 2025 Annual Results: Dual Engines of Innovative R&D and Global Collaboration Propel Revenue Past RMB 10 Billion Milestone
Authoritative Recognition, Accelerating Clinical PenetrationPaclitaxel Oral Solution (Liporaxel®) was officially included in the 2025 CSCO Guidelines for the Diagnosis and Treatment of Gastric Cancer as a Grade I recommendation (Category 1A) for the second-line treatment of advanced
More news about: 3SBio Inc.